The largest database of trusted experimental protocols

Anxa1

Manufactured by R&D Systems
Sourced in United Kingdom

ANXA1 is a protein that belongs to the annexin family. Annexins are calcium-dependent phospholipid-binding proteins involved in various cellular processes, including membrane organization, cell division, and signal transduction. ANXA1 plays a role in the regulation of inflammatory responses and the resolution of inflammation.

Automatically generated - may contain errors

4 protocols using anxa1

1

Exosome Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exosome flow-cytometry analysis was performed as previously described15 . Briefly, exosomes preparations (15 μg) were incubated with 10 μL of 4-μm-diameter aldehyde/sulfate latex beads (Life Technologies) for 15 min at RT, then resuspended in 1 mL PBS and incubated on a test tube rotator wheel overnight at 4 °C. Free binding sites on beads were saturated with 110 μl of 1 M glycine at RT for 30 min. Exosomes-coated beads were resuspended into 400 μL PBS containing 2% BSA and a 25 μL aliquot was incubated with the following antibodies: CD63 (sc-5275, Santa Cruz), CD9 (#655433, BD Bioscience), TSG101 (ab83, Abcam), ANXA1 (AF3770, R&D Biosystems), H2AFZ (sc-67218, Santa Cruz), HSPA8 (NB100-41377, Novus), PKM2 (D78A4, Cell Signaling), and anti-human IgG (#409309, BioLegend), or an isotype-matched negative control antibody for 30 min at 4 °C followed, when needed, by incubation with FITC-conjugated secondary antibody (BD Bioscience). One microgram of primary and secondary antibody was used for all stainings. Flow-cytometry data were acquired on a Gallios flow cytometer (Beckman Coulter) and analyzed using FlowJo.
+ Open protocol
+ Expand
2

Intracranial Hemorrhage Protocol with Annexin A1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human Annexin A1 protein (AnxA1, R&D Systems) and the FPR2 antagonist N-t-butyloxycarbonyl-Phe-DLeu-Phe-DLeu-Phe (Boc2; MP Biomedicals), and SB203580 (an inhibitor of p38 MAPK, Santa Cruz Biotechnology) were dissolved in 2μl sterile PBS. AnxA1 was administered i.c.v. at 0.5 hour after ICH induction. Boc2 (0.8μg/mouse) and SB203580(0.4μg/mouse) was given 1 hour before ICH induction via intracerebroventricular injection. Vehicle animals received the same volume of PBS injection. All drugs were administered to the contralateral side of hemorrhage to avoid interaction with collagenase.
+ Open protocol
+ Expand
3

Therapeutic effects of Annexin A1 in GMH

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were divided randomly into two groups, which either received intraperitoneal or intranasal administration of Human recombinant Annexin A1 (AnxA1, R&D Systems) at a low and high concentration at 1 h after GMH induction and given for three consecutive days. Dosage concentrations for annexin A1 were modifed from the following study (Ding et al., 2020 (link)). The following groups were randomly assigned: Sham, GMH + Vehicle, GMH + AnxA1 (I⋅P, 0.5 μg/rat pup), GMH + AnxA1 (I·P 1.5 μg/rat pup), GMH + AnxA1(in 0.05 μg/ rat pup), and GMH + AnxA1 (0.0150 μg/rat pup). Hemoglobin assay and short-term neurobehavior were used to evaluate the best dosing regimen at 72 h post-ictus.
+ Open protocol
+ Expand
4

Islet Incubation with ANXA1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human islets (100 per dish) were incubated in non-treated petri dishes containing RPMI-1640 supplemented with 10% (vol./vol.) FBS and 1% (vol./vol.) pen-strep, either alone or in the presence of ANXA1 (R&D Systems Abingdon, UK), for 2 days. Co-cultures of human islets and hASCs were performed in parallel as positive controls, as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!